Introducing Cytocine™: Primary Porcine Hepatocytes

Cytocine™ Cryopreserved Primary Porcine Hepatocytes offer a valuable alternative to human hepatocytes for preclinical research applications. With high viability, plateability, metabolic functionality, and scalability, Cytocine™ hepatocytes provide a reliable and cost-effective solution for researchers who need a consistent supply of cells for their experiments. Dive into our latest White Paper to learn more about this new source of high-quality liver cells to support biomedical research.

Introducing Cytocine™: Primary Porcine Hepatocytes

We’re excited to introduce our newest product line, CytocineTM Primary Porcine Hepatocytes. These cells are currently available for sale.

To learn more about the value of Primary Porcine Hepatocytes, check out out our White Paper, Cytocine™ Cryopreserved Primary Porcine Hepatocytes: A Reliable, Scalable Solution for Biomedical Research. This outlines the advantages of using porcine hepatocytes as an reliable alternative to human liver cells for drug development, toxicology, and liver disease studies.

Explore how Cytocine™ provides high viability, full metabolic functionality, and consistent scalability—making it a powerful and cost-effective option for researchers worldwide.

🔗 Read the full white paper here

Get the insights you need to drive your research forward with Cytocine™. From drug metabolism studies to high-throughput screening, this resource is a must-read for anyone involved in liver-related biomedical research.

Featured Content

Covid-19 Statement

We are committed to our work and the wellness of our communities, and will remain so during this challenging and uncertain time of COVID-19.

Read More »